BIO Partnering™ Now Open for Global Collaboration
The BIO Partnering™ platform for BIO 2026 is now officially open, offering a powerful opportunity for professionals across the life sciences sector to connect with biotech companies, pharmaceutical leaders, investors, and innovators worldwide.
As participation continues to grow, early engagement is essential for maximizing visibility and securing valuable meetings. The platform is designed to streamline networking and foster strategic partnerships that drive innovation across the biotechnology ecosystem.
A Strategic Tool for Biotech and Pharma Networking
BIO Partnering™ provides a structured environment where organizations can identify and connect with potential collaborators aligned with their scientific, commercial, and investment goals.
Available exclusively through Premier Access, the platform enables participants to explore attending companies, schedule one-on-one meetings, and build meaningful connections ahead of the event. Early registration incentives, including discounted rates, encourage timely participation and preparation.
Optimizing Your Partnering Strategy
To help participants maximize the platform’s potential, BIO offers a guided approach to building an effective partnering strategy:
- Refine your profile: Clearly present your organization, capabilities, and objectives to stand out
- Identify key targets: Use advanced search and filtering tools to find relevant partners
- Send focused meeting requests: Craft personalized and strategic outreach messages
- Organize your schedule: Build a structured calendar to optimize on-site meetings
Additionally, the platform includes AI-assisted tools to support users in creating targeted and effective meeting requests, enhancing engagement and response rates.
Learn How to Navigate the Platform
Participants can further enhance their experience by joining an upcoming webinar on April 16, 2026, which will provide a practical walkthrough of the BIO Partnering™ system.
The session will cover essential topics such as profile optimization, partner identification, and effective communication strategies, helping attendees move efficiently from setup to confirmed meetings.
Backed by Industry Leaders
BIO 2026 is supported by major global players in the biotechnology and pharmaceutical industries, including:
- Amgen
- Eli Lilly
- Genentech
- Merck
- Sanofi
- Novo Nordisk
- Boehringer Ingelheim
Their participation highlights the importance of BIO Partnering™ as a central hub for innovation, deal-making, and collaboration in the life sciences sector.
Accelerating Innovation Through Strategic Partnerships
In an increasingly competitive and fast-paced research environment, the ability to connect quickly and effectively with the right partners is critical. BIO Partnering™ addresses this need by providing a digital infrastructure that supports efficient collaboration and accelerates the path from discovery to commercialization.
As BIO 2026 approaches, early engagement with the platform can make a significant difference in building partnerships, advancing projects, and unlocking new opportunities in biotechnology and healthcare innovation.